LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Inflammatory Marker Levels Established In Specific Obese Adolescents

By LabMedica International staff writers
Posted on 21 Mar 2012
Levels of inflammatory biomarkers in the blood have been measured in obese adolescents who are glucose intolerant and possibly prediabetic.

Increased levels of systemic inflammatory markers, such as C-reactive protein (CRP), the cytokine interleukin-6 (IL-6) and elevated pteridine derivatives as well as specific enzyme levels may be influenced by glucose intolerance.

At the Ege University, (Izmir, Turkey) scientists performed oral glucose tolerance tests (OGTT) on 45 pubertal obese children, 23 girls and 22 boys with a mean age of 13.52 years. Biochemical analyses were performed on the sample collection day, that included glucose, insulin, glycated hemoglobin (HbA1c), total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), apolipoprotein AI (Apo A), apolipoprotein B100 (Apo B), CRP, IL-6, neopterin levels, complete blood count and chitotriosidase activities. Serum chitotriosidase activity was measured by a fluorescence method and fasting serum concentrations of IL-6 and neopterin were determined by the use of commercial enzyme-linked immunosorbent assays (ELISA).

In 21 children, normal glucose tolerance (NGT) was observed being defined as fasting glucose levels of less than 5.6 mmol/L and two hour glucose levels of less than 7.8 mmol/L. Impaired glucose tolerance (IGT) was found in 24 children where after the OGTT, the two hour glucose levels were between 7.8 and 11.1 mmol/L. The IL-6 and CRP levels were similar in the two groups. There was no significant difference in the lipid profiles or serum neopterin levels between the groups. However, the chitotriosidase activity was significantly higher in the IGT group at 124.33 ± 51.97 μmol/L/hour than the NGT group where the mean activity was 84.50 ± 53.99 μmol/L/hour. The chitotriosidase activity was measured on the F-2500 fluorometer (Hitachi Ltd., Tokyo, Japan). The fasting serum concentrations of IL-6 was determined by the ELISA kit from DIA Source (Louvain-La-Neuve, Belgium) and neopterin levels with an ELISA from DRG Instruments, (Marburg, Germany).

Activated macrophages secrete several proteins, like neopterin and chitotriosidase, which could influence the atherosclerotic process, leading to a local inflammation in the vessel wall. The authors concluded that the results of their study show that serum chitotriosidase activity is increased in obese adolescents with impaired glucose tolerance. Impaired glucose tolerant state is an important period in which atherosclerotic lesions start to emerge. The results demonstrate that the existence of glucose intolerance may aggravate the local inflammation, which mainly occurs in the vascular bed in obese children. The study was published in the March 2012 issue of the journal Clinical Biochemistry.

Related Links:
Ege University
Hitachi Ltd.
DIA Source



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more